![Nisha Nanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nisha Nanda's former job positions include Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014, Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023, and Independent Director at Morphic Holding, Inc. from 2021 to 2024.
Dr. Nanda obtained undergraduate and doctorate degrees from The University of New South Wales.
Tidigare kända positioner av Nisha Nanda
| Företag | Position | Slut |
|---|---|---|
| MORC HOLD | Direktör/Styrelseledamot | 2024-08-16 |
| LOXO ONCOLOGY INC | Företagsledare/Principal | 2023-05-01 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Företagsledare/Principal | 2014-02-01 |
Nisha Nandas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
40
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
